top of page
Why North America Remains the World's Pharma Innovation Hub: And What That Means for Global Partnerships
North America holds 42% of the global pharma market and leads global R&D. Discover how MENA companies access North American innovation, and why the Santé Canada regulatory advantage changes the equation. | Nexus Pharmalink
4 min read
bottom of page